Clinical trial Recruiting at 2 sites Interventional Ages 18 to 60

Motor Activation Therapy after concussion: a targeted rehabilitation approach

Official title: Postural Motor Activation Deficits After mTBI; Translating Laboratory Findings to Clinical Care

Run by Oregon Health and Science University · NCT07549529 · Data updated 2026-11-12

This study tests a motor-activation focused physical therapy for people with persistent balance problems after a concussion to see if it improves their responses to imbalance.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment80 (estimated)
SponsorOregon Health and Science University
Academic / other
Locations2 sites (Portland, Oregon and 1 other locations)
StatusRecruiting
StartedJune 30, 2026
Main results expectedAugust 30, 2029
Study endsAugust 30, 2029
Registry record updatedSeptember 24, 2026
Trial IDNCT07549529 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–60 with diagnosed mTBI/concussion, more than 2 weeks but less than 6 months since injury, and ongoing symptoms.

Probably not a fit

Patients with non-balance-related mTBI symptoms, significant comorbidities, or those already receiving targeted motor-activation therapy may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial develops an exercise program aimed at improving how the body responds to imbalance after a concussion, using simple wearable sensors for objective measures. It compares a motor-activation physical therapy with standard care physical therapy in adults with recent mTBI and lingering symptoms. The study integrates clinic-friendly testing with still-practical lab-inspired assessments to track improvements in motor activation and balance. Participants will work with clinicians at OHSU and collaborating sites to complete the intervention within a structured rehabilitation framework. The information gathered will help translate research findings into a practical clinical approach for post-concussion rehab.

Why it matters

Potential benefit: If successful, patients may experience better balance and quicker recovery of motor responses after a concussion.

How similar studies have gone: Prior work suggests that targeted motor activation approaches show promise in improving balance-related outcomes, though this exact approach is being translated to a clinical setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosed mTBI (concussion)
* 18-60 years of age
* More than 2 weeks from the date of the most recent mTBI
* Less than 6 months from the most recent mTBI
* Persisting symptoms from the mTBI

Exclusion Criteria:

* Injury, medical, or neurological illness that could explain balance issues
* Moderate to severe substance abuse in the past month
* Display behavior that would interfere with safety during data collection
* Significant pain during the study period (\> 7/10)
* Pregnancy
* Persistent use of medications that cause balance impairment during the study
* Active in physical therapy services for mTBI symptoms

Where it's running

  • OHSU Balance Disorders Laboratory
    Portland, Oregon, United States
    Recruiting
  • University of Utah Neuromechanics and Applied Locomotion Laboratory
    Salt Lake City, Utah, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.